We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.75%
2 Industrials 5.88%
3 Consumer Discretionary 5.39%
4 Technology 4.75%
5 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
4001
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-2,771
Closed -$78K
QUOT
4002
DELISTED
Quotient Technology Inc
QUOT
-2,183
Closed -$26K
AMRS
4003
DELISTED
Amyris Inc.
AMRS
-1,555
Closed -$6K
UBP
4004
DELISTED
Urstadt Biddle Properties Inc.
UBP
-1,963
Closed -$33K
SPPI
4005
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-4,160
Closed -$79K
NSL
4006
DELISTED
NUVEEN SENIOR INCM FD
NSL
-200
Closed -$1K
MLVF
4007
DELISTED
Malvern Bancorp, Inc.
MLVF
-1,099
Closed -$29K
ISEE
4008
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-1,288
Closed -$4K
NYMX
4009
DELISTED
Nymox Pharmaceutical Corp
NYMX
-1,851
Closed -$6K
GER
4010
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
-11
Closed -$1K
HVBC
4011
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
-100
Closed -$2K
UNAM
4012
DELISTED
Unico American Corp
UNAM
-19
Closed
APTO
4013
DELISTED
Aptose Biosciences, Inc.
APTO
0
KBAL
4014
DELISTED
Kimball International
KBAL
-5,315
Closed -$99K
CSII
4015
DELISTED
Cardiovascular Systems, Inc.
CSII
-39
Closed -$1K
NKG
4016
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
-117
Closed -$1K
NVCN
4017
DELISTED
Neovasc Inc.
NVCN
0
SJR
4018
DELISTED
Shaw Communications Inc.
SJR
-1,596
Closed -$36K
AGFS
4019
DELISTED
AgroFresh Solutions Inc
AGFS
-4,348
Closed -$32K
ASPU
4020
DELISTED
ASPEN GROUP, INC.
ASPU
-1,415
Closed -$13K
ATCO
4021
DELISTED
Atlas Corp.
ATCO
-1,665
Closed -$12K
MYOV
4022
DELISTED
Myovant Sciences Ltd.
MYOV
-4,741
Closed -$60K
CAJ
4023
DELISTED
Canon, Inc.
CAJ
-106
Closed -$4K
ALBO
4024
DELISTED
Albireo Pharma Inc
ALBO
-65
Closed -$2K
RFP
4025
DELISTED
Resolute Forest Products Inc.
RFP
$0 ﹤0.01%
42
-919
-96% -$8.57K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.